Cardiol Therapeutics Inc.: Cardiol Therapeutics Commences Mu

The Cleveland Clinic and the Mayo Clinic Study Sites have been Initiated and are Eligible to Recruit ParticipantsInitiation of Additional U.S. Cardiovascular Research Centers is Planned for Q1, 2023 Oakville

Related Keywords

United States , American , Trevor Burns , Allanl Klein , David Elsley , Company Phase , Vascular Institute , Drug Administration , Virginia Commonwealth University , American Heart Association Scientific Sessions , Company Annual Information Form , Nasdaq , Cardiol Therapeutics Inc , Newsfile Corp , Cleveland Clinic , Mayo Clinic Study Sites , Research Centers , Mayo Clinic , Cardiol Therapeutic President , Chief Executive , Pericardial Diseases , Investigational New Drug Application , United States Food , Cardiol Therapeutics , Annual Information Form , Investor Relations , Cardiol , Herapeutics , Ommences , Ulti , Center , Hase , Pilot , Study , Ardiolrx , Treatment , Recurrent , Pericarditis ,